SMVLX
Price
$92.88
Change
+$0.56 (+0.61%)
Updated
Jun 2 closing price
Net Assets
3.88B
VIVIX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

SMVLX vs VIVIX

Header iconSMVLX vs VIVIX Comparison
Open Charts SMVLX vs VIVIXBanner chart's image
SMVLX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
SMVLX vs. VIVIX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMVLX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 238B vs. SMVLX (3.88B). VIVIX pays higher dividends than SMVLX: VIVIX (1.87) vs SMVLX (1.48). SMVLX was incepted earlier than VIVIX: SMVLX (18 years) vs VIVIX (28 years). SMVLX (1.23) is less costly to investors than VIVIX (0.03). SMVLX is a more actively managed with annual turnover of: 16.25 vs. VIVIX (8.00). SMVLX has a lower initial minimum investment than VIVIX: SMVLX (3000) vs VIVIX (5000000). SMVLX annual gain was more profitable for investors over the last year : 29.77 vs. VIVIX (23.24). VIVIX (50.71) and SMVLX (49.38) have equivalent 5 years return.
SMVLXVIVIXSMVLX / VIVIX
Total Expense Ratio1.230.034,100%
Annual Report Gross Expense Ratio1.230.034,100%
Fund Existence18 years28 years-
Gain YTD12.94310.670121%
Front LoadN/AN/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.88B238B2%
Annual Yield % from dividends1.481.8779%
Returns for 1 year29.7723.24128%
Returns for 3 years46.9153.1888%
Returns for 5 years49.3850.7197%
Returns for 10 years160.90150.42107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXG5.080.67
+15.19%
Addentax Group Corp
ELVA12.260.93
+8.21%
Electrovaya
AIRG7.380.28
+3.94%
Airgain
CALY15.09-0.15
-0.98%
Callaway Golf Company
NBIX154.86-6.14
-3.81%
Neurocrine Biosciences